Comparison of efficacy of peptilose-base ORS (ORALNU) and WHO-ORS

J Med Assoc Thai. 1993 Oct:76 Suppl 2:42-8.

Abstract

We examined whether replacing glucose with Peptilose into standard ORS would be advantageous over WHO-ORS. A study was carried out on 134 diarrheal children with mild to moderate dehydration. They received either WHO-ORS or Peptilose-ORS by randomized selection. In only two cases in each group, diarrhea was caused by Vibrio cholerae non 0-1. Significant per cent weight gain was observed in patients with Peptilose-ORS compared to those treated with WHO-ORS (P = 0.046). The patients could voluntarily take a higher amount of Peptilose-ORS and had significantly less stool output in the combined mildly and moderately dehydrated patients. It is concluded that Peptilose-ORS is more advantageous and acceptable than the standard WHO glucose-ORS for treatment of non cholera and 2 cases of cholera dehydrating diarrhea in children.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Amino Acids
  • Diarrhea, Infantile / therapy*
  • Female
  • Humans
  • Infant
  • Male
  • Oligosaccharides
  • Peptides
  • Prospective Studies
  • Rehydration Solutions*

Substances

  • Amino Acids
  • Oligosaccharides
  • Peptides
  • Rehydration Solutions
  • peptilose